Extracorporeal life support in adults with hemodynamic collapse from fulminant cardiomyopathies

the chance of bridging to recovery

Ta Wei Su, Yuan His Tseng, Tzu I. Wu, Pyng Jing Lin, Meng Yu Wu

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Venoarterial extracorporeal life support (VA-ECLS) is a lifesaving circulatory support in hemodynamic collapse induced by miscellaneous etiologies. However, survival rates vary among etiologies. To investigate the therapeutic effectiveness of VAECLS in hemodynamic collapse induced by fulminant cardiomyopathy (CM), a retrospective chart review of 14 patients was conducted, among the 294 adults receiving VA-ECLS in a single institution from April 2006 to April 2013. All patients received echocardiography, coronary angiography, or computed tomography before or immediately after undergoing VA-ECLS to exclude anatomic cardiac diseases. Myocarditis (n = 12) and peripartum CM (n = 2) were the subcategories of fulminant CM. The median door-to-ECLS duration was 12 hours. Seven patients received cardiopulmonary resuscitation (CPR) before VA-ECLS, and three required ECLS-assisted CPR to regain circulation. Two patients were transplanted as a result of myocardial irreversibility and one survived. Nine of the nontransplant patients survived after a median VA-ECLS of 167 hours. All of the 10 survivors, including the five experiencing dialysis-dependent acute renal failure, had their cardiac and renal function return to normal within 6 months after the episode. The VA-ECLS was a practical therapeutic option in fulminant CM. It could provide expeditious hemodynamic support and preserve organ viability essential to recovery. ASAIO Journal 2014; 60:664-669.

Original languageEnglish
Pages (from-to)664-669
Number of pages6
JournalASAIO Journal
Volume60
Issue number6
DOIs
Publication statusPublished - 2014

Fingerprint

Extracorporeal Membrane Oxygenation
Hemodynamics
Cardiomyopathies
Resuscitation
Recovery
Echocardiography
Regain
Angiography
Dialysis
Cardiopulmonary Resuscitation
Tomography
Peripartum Period
Tissue Survival
Myocarditis
Coronary Angiography
Acute Kidney Injury
Survivors
Heart Diseases
Survival Rate
Kidney

Keywords

  • Cardiac arrest
  • Extracorporeal life support
  • Extracorporeal membrane oxygenation
  • Myocarditis
  • Peripartum cardiomyopathy

ASJC Scopus subject areas

  • Biophysics
  • Biomaterials
  • Bioengineering
  • Biomedical Engineering
  • Medicine(all)

Cite this

Extracorporeal life support in adults with hemodynamic collapse from fulminant cardiomyopathies : the chance of bridging to recovery. / Su, Ta Wei; Tseng, Yuan His; Wu, Tzu I.; Lin, Pyng Jing; Wu, Meng Yu.

In: ASAIO Journal, Vol. 60, No. 6, 2014, p. 664-669.

Research output: Contribution to journalArticle

Su, Ta Wei ; Tseng, Yuan His ; Wu, Tzu I. ; Lin, Pyng Jing ; Wu, Meng Yu. / Extracorporeal life support in adults with hemodynamic collapse from fulminant cardiomyopathies : the chance of bridging to recovery. In: ASAIO Journal. 2014 ; Vol. 60, No. 6. pp. 664-669.
@article{05b89651688f4188bde1226c25ae39b4,
title = "Extracorporeal life support in adults with hemodynamic collapse from fulminant cardiomyopathies: the chance of bridging to recovery",
abstract = "Venoarterial extracorporeal life support (VA-ECLS) is a lifesaving circulatory support in hemodynamic collapse induced by miscellaneous etiologies. However, survival rates vary among etiologies. To investigate the therapeutic effectiveness of VAECLS in hemodynamic collapse induced by fulminant cardiomyopathy (CM), a retrospective chart review of 14 patients was conducted, among the 294 adults receiving VA-ECLS in a single institution from April 2006 to April 2013. All patients received echocardiography, coronary angiography, or computed tomography before or immediately after undergoing VA-ECLS to exclude anatomic cardiac diseases. Myocarditis (n = 12) and peripartum CM (n = 2) were the subcategories of fulminant CM. The median door-to-ECLS duration was 12 hours. Seven patients received cardiopulmonary resuscitation (CPR) before VA-ECLS, and three required ECLS-assisted CPR to regain circulation. Two patients were transplanted as a result of myocardial irreversibility and one survived. Nine of the nontransplant patients survived after a median VA-ECLS of 167 hours. All of the 10 survivors, including the five experiencing dialysis-dependent acute renal failure, had their cardiac and renal function return to normal within 6 months after the episode. The VA-ECLS was a practical therapeutic option in fulminant CM. It could provide expeditious hemodynamic support and preserve organ viability essential to recovery. ASAIO Journal 2014; 60:664-669.",
keywords = "Cardiac arrest, Extracorporeal life support, Extracorporeal membrane oxygenation, Myocarditis, Peripartum cardiomyopathy",
author = "Su, {Ta Wei} and Tseng, {Yuan His} and Wu, {Tzu I.} and Lin, {Pyng Jing} and Wu, {Meng Yu}",
year = "2014",
doi = "10.1097/MAT.0000000000000141",
language = "English",
volume = "60",
pages = "664--669",
journal = "ASAIO Journal",
issn = "1058-2916",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Extracorporeal life support in adults with hemodynamic collapse from fulminant cardiomyopathies

T2 - the chance of bridging to recovery

AU - Su, Ta Wei

AU - Tseng, Yuan His

AU - Wu, Tzu I.

AU - Lin, Pyng Jing

AU - Wu, Meng Yu

PY - 2014

Y1 - 2014

N2 - Venoarterial extracorporeal life support (VA-ECLS) is a lifesaving circulatory support in hemodynamic collapse induced by miscellaneous etiologies. However, survival rates vary among etiologies. To investigate the therapeutic effectiveness of VAECLS in hemodynamic collapse induced by fulminant cardiomyopathy (CM), a retrospective chart review of 14 patients was conducted, among the 294 adults receiving VA-ECLS in a single institution from April 2006 to April 2013. All patients received echocardiography, coronary angiography, or computed tomography before or immediately after undergoing VA-ECLS to exclude anatomic cardiac diseases. Myocarditis (n = 12) and peripartum CM (n = 2) were the subcategories of fulminant CM. The median door-to-ECLS duration was 12 hours. Seven patients received cardiopulmonary resuscitation (CPR) before VA-ECLS, and three required ECLS-assisted CPR to regain circulation. Two patients were transplanted as a result of myocardial irreversibility and one survived. Nine of the nontransplant patients survived after a median VA-ECLS of 167 hours. All of the 10 survivors, including the five experiencing dialysis-dependent acute renal failure, had their cardiac and renal function return to normal within 6 months after the episode. The VA-ECLS was a practical therapeutic option in fulminant CM. It could provide expeditious hemodynamic support and preserve organ viability essential to recovery. ASAIO Journal 2014; 60:664-669.

AB - Venoarterial extracorporeal life support (VA-ECLS) is a lifesaving circulatory support in hemodynamic collapse induced by miscellaneous etiologies. However, survival rates vary among etiologies. To investigate the therapeutic effectiveness of VAECLS in hemodynamic collapse induced by fulminant cardiomyopathy (CM), a retrospective chart review of 14 patients was conducted, among the 294 adults receiving VA-ECLS in a single institution from April 2006 to April 2013. All patients received echocardiography, coronary angiography, or computed tomography before or immediately after undergoing VA-ECLS to exclude anatomic cardiac diseases. Myocarditis (n = 12) and peripartum CM (n = 2) were the subcategories of fulminant CM. The median door-to-ECLS duration was 12 hours. Seven patients received cardiopulmonary resuscitation (CPR) before VA-ECLS, and three required ECLS-assisted CPR to regain circulation. Two patients were transplanted as a result of myocardial irreversibility and one survived. Nine of the nontransplant patients survived after a median VA-ECLS of 167 hours. All of the 10 survivors, including the five experiencing dialysis-dependent acute renal failure, had their cardiac and renal function return to normal within 6 months after the episode. The VA-ECLS was a practical therapeutic option in fulminant CM. It could provide expeditious hemodynamic support and preserve organ viability essential to recovery. ASAIO Journal 2014; 60:664-669.

KW - Cardiac arrest

KW - Extracorporeal life support

KW - Extracorporeal membrane oxygenation

KW - Myocarditis

KW - Peripartum cardiomyopathy

UR - http://www.scopus.com/inward/record.url?scp=84927689833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927689833&partnerID=8YFLogxK

U2 - 10.1097/MAT.0000000000000141

DO - 10.1097/MAT.0000000000000141

M3 - Article

VL - 60

SP - 664

EP - 669

JO - ASAIO Journal

JF - ASAIO Journal

SN - 1058-2916

IS - 6

ER -